Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Editorials

Blinatumomab and better BCR::ABL1 inhibition begets better bone marrow transplant outcomes

Division of Leukemia, Department of Medicine, Dana-Farber Cancer Institute, Boston
Knight Cancer Institute, Oregon Health and Science University
Haematologica Early view Jun 12, 2025 https://doi.org/10.3324/haematol.2025.288068

Abstract

Not available.

Figures & Tables

Article Information

Early view : Editorials
 
DOI
https://doi.org/10.3324/haematol.2025.288068
Pubmed
40501389
 
Published
2025-06-12
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2025 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
159
PDF Downloads
79

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2025 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online